Prime Medicine to attend upcoming investor conferences

CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a novel class of differentiated, one-time cure genetic therapies, today announced that the company’s management will participate in the following upcoming conferences:

• Morgan Stanley22^nd Annual Global Healthcare Conference: Fireside Conversation on Wednesday, September 4, 2024 at 1:05 PM ET in New York, NY.
• Wells Fargo Healthcare Conference: Fireside Talk on Thursday, September 5, 2024 at 11:00am ET in Boston, MA.
• Cantor Global Healthcare Conference: The Company’s management will host a one-on-one investor meeting in New York, NY on Tuesday, September 17, 2024.
• Chardan’s 8^and Annual Conference on Genetic Medicines: Fireside Talk at 1:30 pm ET and Panel Discussion, “Gene Insertion and Gene Correction,” at 5:40 pm ET on Monday, September 30, 2024 in New York, NY.

Live audio webcasts of each presentation will be available under “Events & Presentations” in the News & Events section of the Company’s website at www.primemedicine.com. Replays of each webcast will be available on Prime Medicine’s website for 90 days following the event.